Clorox (CLX) FY2016 results: revenue $5.8 billion, up 1.9% on the year
Clorox Co. (CLX) reported revenue of $5.8 billion for fiscal 2016, the year ended 30 June 2016, up 1.9% on the year before. Net income was $648 million, up 11.7%, and diluted earnings per share $4.92. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2018.
Revenue
$5.8 billion
+1.9% on the year
FY2009FY2016
Operating margin
n/a
FY2009FY2016
Net income
$648 million
+11.7% on the year
FY2009FY2016
Diluted EPS
$4.92
+12.6% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
5,761
5,655
5,514
+1.9%
Cost of revenue
3,163
3,190
3,158
-0.8%
Gross profit
2,598
2,465
2,360
+5.4%
Gross margin
45.1%
43.6%
42.8%
Research and development
141
136
125
+3.7%
Selling, general and administrative
806
798
751
+1.0%
Interest expense
88.0
100
103
-12.0%
Pre-tax income
983
921
884
+6.7%
Income tax
335
315
305
+6.3%
Effective tax rate
34.1%
34.2%
34.5%
Net income
648
580
558
+11.7%
Net margin
11.2%
10.3%
10.1%
Diluted EPS
$4.92
$4.37
$4.23
+12.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
778
874
767
-11.0%
Capital expenditure
172
125
137
+37.6%
Free cash flow
606
749
630
-19.1%
Free cash flow margin
10.5%
13.2%
11.4%
Cash from investing
-430
-106
-138
Cash from financing
-316
-696
-592
Depreciation and amortisation
165
169
177
-2.4%
Share-based compensation
45.0
32.0
36.0
+40.6%
Buybacks
254
434
260
-41.5%
Dividends paid
398
385
368
+3.4%
Dividend per share
$3.11
$2.99
$2.87
+4.0%
Diluted shares, weighted
132m
133m
132m
-0.8%
Shares outstanding at period end
129m
129m
129m
+0.6%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
297
118
154
+151.7%
Debt
2,312
2,096
2,313
+10.3%
Other liabilities
1,909
1,940
1,791
-1.6%
Total liabilities and equity
4,518
4,154
4,258
+8.8%
Fixed assets
906
918
977
-1.3%
Goodwill
1,197
1,067
1,101
+12.2%
Intangible assets
735
585
611
+25.6%
Cash and equivalents
401
382
329
+5.0%
Receivables
569
519
546
+9.6%
Inventory
443
385
386
+15.1%
Other assets
267
298
308
-10.4%
Total assets
4,518
4,154
4,258
+8.8%
10-K for the year ended 30 June 2016, filed 14 August 2018: the filing.